1. Higashi-Kuwata N, Hayashi S, Kumamoto H, Ogata-Aoki H, Das D, Venzon D, Hattori SI, Bulut H, Hashimoto M, Otagiri M, Takamune N, Kishimoto N, Davis DA, Misumi S, Kakuni M, Tanaka Y, Mitsuya H. Identification of a novel long-acting 4'-modified nucleoside reverse transcriptase inhibitor against HBV. J Hepatol. 2021,3, S0168-8278(20)33843-5. doi: 10.1016/j.jhep.2020.12.006.
2. Hashimoto M, Taguchi K, Imoto S, Yamasaki K, Mitsuya H, Otagiri M. Pharmacokinetics of 4'-cyano-2'-deoxyguanosine, a novel nucleoside analog inhibitor of the resistant hepatitis B virus, in a rat model of chronic kidney disease. J Infect Chemother. 2021,3,27, 702-6. doi: 10.1016/j.jiac.2020.12.014.
3. Goto M, Azuma K, Arima H, Kaneko S, Higashi T, Motoyama K, Michihara A, Shimizu T, Kadowaki D, Maruyama T, Otagiri M, Iohara D, Hirayama F, Anraku M. Sacran, a sulfated polysaccharide, suppresses the absorption of lipids and modulates the intestinal flora in non-alcoholic steatohepatitis model rats. Life Sci. 2021,3, 268, 118991. doi: 10.1016/j.lfs.2020.118991.
4. Anraku M, Mizukai Y, Maezaki Y, Kawano K, Okazaki S, Takeshita K, Adachi T, Otagiri M, Iohara D, Hirayama F. The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseases. Carbohydr Polym. 2021,2, 253, 117246. doi: 10.1016/j.carbpol.2020.117246.
5. Yamasaki K, Nishi K, Tsukigawa K, Taguchi K, Otagiri M, Seo H. Possible Role of Electrolytes on the Formation of Precipitates during the Infusion of Nafamostat Mesilate in Hemodialysis. Biol Pharm Bull. 2021,2, 44, 259-65. doi: 10.1248/bpb.b20-00808.
6. Yamasaki K, Kawai A, Sakurama K, Udo N, Yoshino Y, Saito Y, Tsukigawa K, Nishi K, Otagiri M. Interaction of Benzbromarone with Subdomains IIIA and IB/IIA on Human Serum Albumin as the Primary and Secondary Binding Regions. Mol Pharm. 2021,1, 18, 1061-70. doi: 10.1021/acs.molpharmaceut.0c01004.
7. 山田孫平、松平崇、山本恵三、酒井宏水. NADHとヘモグロビンの共存による抗酸化的な擬似酵素活性と人工赤血球への応用. 人工血液. 2020,12, 28(1), 49-56.
8. Goto M, Iohara D, Michihara A, Ifuku S, Azuma K, Kadowaki D, Maruyama T, Otagiri M, Hirayama F, Anraku M. Effects of surface-deacetylated chitin nanofibers on non-alcoholic steatohepatitis model rats and their gut microbiota. Int J Biol Macromol, 2020, 164, 659-66. doi: 10.1016/j.ijbiomac.2020.12.07.184.
9. Tsukigawa K, Imoto S, Yamasaki K, Nishi K, Tsutsumi T, Yokoyama S, Ishima Y, Otagiri M. Synthesis and In Vitro Assessment of pH-Sensitive Human Serum Albumin Conjugates of Pirarubicin. Pharmaceuticals (Basel). 2020,12, 14, 22. doi: 10.3390/ph14010022.
10. Y. Yoshida, T. Nagamori, E. Ishibazawa, H. Kobayashi, T. Kure, H. Sakai, D. Takahashi, M. Fujihara, H. Azuma. Contribution of long chain fatty acid to induction of myeloid-derived suppressor cell (MDSC)-like cells - Induction of MDSC by lipid vesicles (liposome) - Immunopharmacol. Immunotoxicol. 2020,11, 42, 614-24, doi: 10.1080/08923973.2020.1837866